JoAnne Alkire - Merit Medical Executive Strategy
| MMSI Stock | USD 74.10 0.99 1.32% |
Executive
JoAnne Alkire is Executive Strategy of Merit Medical Systems
| Address | 1600 West Merit Parkway, South Jordan, UT, United States, 84095 |
| Phone | 801 253 1600 |
| Web | https://www.merit.com |
Merit Medical Management Efficiency
The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0805 %, meaning that it created $0.0805 on every $100 dollars invested by stockholders. Merit Medical's management efficiency ratios could be used to measure how well Merit Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Merit Medical's Return On Capital Employed is increasing as compared to previous years. The Merit Medical's current Return On Assets is estimated to increase to 0.05, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Merit Medical's Total Current Assets are increasing as compared to previous years. The Merit Medical's current Intangible Assets is estimated to increase to about 342.2 M, while Other Assets are projected to decrease to under 25.7 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Emily Mattacchione | Novo Integrated Sciences | 43 | |
| Lynette CPA | Pennant Group | 47 | |
| Lyn Ketelsen | HCA Holdings | N/A | |
| Joseph III | HCA Holdings | 67 | |
| Martin Paslick | HCA Holdings | 64 | |
| MD MBA | HCA Holdings | 58 | |
| Kirk Cheney | Pennant Group | N/A | |
| Heather CPA | Acadia Healthcare | 52 | |
| Chad Wasserman | HCA Holdings | N/A | |
| Chen Zhang | Aesthetic Medical Intl | N/A | |
| Qing Hu | Aesthetic Medical Intl | 60 | |
| Bill Priest | Acadia Healthcare | N/A | |
| Mark Palmenter | Acadia Healthcare | N/A | |
| Frank CFA | HCA Holdings | N/A | |
| Kathleen JD | HCA Holdings | 60 | |
| Jim Brown | HCA Holdings | N/A | |
| Gretchen Hommrich | Acadia Healthcare | N/A | |
| Laura Groschen | Acadia Healthcare | N/A | |
| Nasser MD | Acadia Healthcare | N/A | |
| Klara Radulyne | Novo Integrated Sciences | 38 | |
| Michael Marks | HCA Holdings | 53 | |
Management Performance
| Return On Equity | 0.0805 | ||||
| Return On Asset | 0.0399 |
Merit Medical Systems Leadership Team
Elected by the shareholders, the Merit Medical's board of directors comprises two types of representatives: Merit Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merit. The board's role is to monitor Merit Medical's management team and ensure that shareholders' interests are well served. Merit Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merit Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Stillabower, Independent Director | ||
| Franklin Miller, Independent Director | ||
| Bernard Birkett, CFO | ||
| Fred Lampropoulos, Chairman, CEO and Pres | ||
| Joseph Wright, President - International Division | ||
| Jill Anderson, Director | ||
| Neil Peterson, Chief Officer | ||
| Elizabeth Huebner, Director | ||
| Kent Stanger, CFO, Secretary, Treasurer, Director | ||
| AnneMarie Wright, Vice President - Corporate Communications | ||
| Brian Lloyd, Chief Legal Officer, Corporate Secretary | ||
| Raul Parra, Interim CFO | ||
| Justin Lampropoulos, Executive Vice President - Sales, Marketing and Strategy | ||
| Richard Edelman, Independent Director | ||
| F Millner, Independent Director | ||
| CPA Parra, CFO Treasurer | ||
| Sarah Comstock, Vice Communications | ||
| JoAnne Alkire, Executive Strategy | ||
| Ronald Frost, COO | ||
| Thomas Gunderson, Independent Director | ||
| David Liu, Director | ||
| Joseph Pierce, Chief Officer | ||
| Nolan Karras, Independent Director | ||
| Nicole Priest, Chief Officer | ||
| Michel Voigt, Chief Officer | ||
| Scott Anderson, Independent Director | ||
| John Knorpp, Chief Officer | ||
| Jason Treft, Chief Officer | ||
| Ann Millner, Independent Director |
Merit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merit Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0805 | ||||
| Return On Asset | 0.0399 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 4.65 B | ||||
| Shares Outstanding | 58.06 M | ||||
| Shares Owned By Insiders | 2.43 % | ||||
| Shares Owned By Institutions | 97.57 % | ||||
| Number Of Shares Shorted | 2.06 M | ||||
| Price To Earning | 956.67 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Merit Stock analysis
When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Merit Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.62 | Revenue Per Share 21.832 | Quarterly Revenue Growth 0.106 | Return On Assets 0.0399 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.